Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: Arizona997 who wrote (728)	12/6/1998 12:04:00 PM
From: Mike McFarland	Respond to of 1255

I've placed my chips on the table I'm afraid I had to take half my chips off to get even in this, been tough trading it. Now that I'm even I will sit back and relax. I read through the letter to shareholders when it arrived last week and have done a little more research. Look forward to seeing a partner, the sudden credibility will send this thing flying...and flying too fast to trade. So you have to have to own the shares now when things are quiet...oh well, sometimes you just plop your money down and invest, it's no crime to have a little faith and enthusiasm. Good luck all. --MM

To: Arizona997 who wrote (728)	12/6/1998 2:00:00 PM
From: John Lacelle	Read Replies (1) \| Respond to of 1255

Gary, I agree. This company is very undervalued if the drug holds up in trial. Even a merger with a Euro Co would be a big breakthrough because the Euros tend to be much more willing to market drugs and they have the money and know-how. In a worst case senario, I bet we could sell ampalex as a "nutritional supplement" in a tea bag with gingo koba and St. John's Wort. It would double your memory and have ya feeling groovy! The baby-boomers miracle drug if there ever was one :*) On with the big money!!! -John